Home Infusion in 2026: Growth, Innovation and the Rising Importance of Revenue Cycle Management

Aug 17
2 min read

Home infusion continues to play an increasingly important role in the U.S. healthcare system as more patients receive complex therapies outside traditional hospital settings.

The National Home Infusion Association (NHIA) reported in March 2026 that the home and alternate-site infusion industry continues to evolve across therapy categories and payer environments. The organization highlighted continued momentum in specialty therapies and IVIG while also identifying reimbursement and policy challenges affecting providers.

For home infusion providers, growth creates an important operational question: How can organizations scale patient care while maintaining an efficient and financially healthy revenue cycle?

Reimbursement Is Becoming More Important

Medicare's home infusion therapy benefit covers certain professional services associated with qualifying home infusion therapies, including nursing, training and education, remote monitoring, and other monitoring services. CMS also publishes specific national and geographically adjusted home infusion therapy rates.

For providers, accurate billing is therefore more than an administrative function. Errors involving eligibility, authorization, coding, documentation, claim submission or payer requirements can create delays in reimbursement and increase accounts receivable.

Prior Authorization Remains a Challenge

Another area receiving attention in 2026 is prior authorization.

NHIA reported in June that it submitted comments to CMS regarding proposed changes to interoperability and prior authorization processes, emphasizing that home infusion can involve different benefit structures and may not fit neatly into processes designed around traditional medical or pharmacy benefits.

This makes front-end revenue cycle management particularly important for infusion providers.

Before services are provided, organizations need processes for:

Insurance eligibility verification
Benefits investigation
Prior authorization
Medical-necessity documentation
Accurate patient information
Payer-specific requirements
Timely claim submission

Why RCM Matters for Home Infusion

As home infusion providers expand, revenue cycle management can become increasingly complex.

A successful RCM process should connect the entire billing lifecycle—from patient intake and authorization through claim submission, denial management, payment posting and accounts receivable follow-up.

For home infusion organizations, the goal isn't simply to submit more claims. It is to reduce avoidable billing errors, identify reimbursement issues earlier and create greater visibility into outstanding accounts.

The Opportunity Ahead

The home infusion industry is positioned for continued growth, particularly as healthcare continues moving appropriate services toward outpatient and home-based settings. Industry analysis also points to increasing demand for infusion services driven by new therapies, an aging population and the movement of care into outpatient and home environments.

For providers, that growth creates an opportunity—but also increases the importance of having scalable operational and financial systems.

At DualPoint Management, we believe effective revenue cycle management should support the entire patient-to-payment process. By combining healthcare billing knowledge with structured claims follow-up, denial management and payer-focused processes, RCM teams can help providers maintain stronger financial operations while remaining focused on patient care.